| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Santos Da Silva Jorge is a Chief Executive Officer at MLTX. Recent filings cover 0 purchases and 11 sales. Those positions are worth an estimated $45.7M at current prices.
Our model assigns Santos Da Silva Jorge a strong insider score of 77/100, based on 9 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +23.4%.
Santos Da Silva Jorge's largest disclosed position is in MLTX as Chief Executive Officer, worth about $45.7M. The recent filings there lean toward selling, a net 486,965 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | MLTX Moonlake Immunotherapeutics | Chief Executive Officer | Sell | 102,225 | $20.02 | $2,046,205.14 | -1.8% | - | - | |
| Dec 9, 2025 | MLTX Moonlake Immunotherapeutics | Chief Executive Officer | Sell | 200,000 | $14.87 | $2,974,700.00 | -3.3% | +25.9% | - | |
| Feb 29, 2024 | MLTX Moonlake Immunotherapeutics | Chief Executive Officer | Sell | 123,615 | $55.03 | $6,803,043.60 | -1.4% | -14.8% | -13.4% | |
| Feb 21, 2024 | MLTX Moonlake Immunotherapeutics | Chief Executive Officer | Sell | 1,125 | $55.27 | $62,178.75 | - | -27.1% | -21.4% | |
| Feb 20, 2024 | MLTX Moonlake Immunotherapeutics | Chief Executive Officer | Sell | 60,000 | $59.26 | $3,555,400.00 | -0.6% | -30.0% | -24.1% |